Medicover AB (publ) (0RPS.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold 0RPS.L in your mock portfolio yet.
The valuation looks stretched relative to current earnings, with a very high PE ratio of 362.37 on modest EPS of 0.59. This implies the market is pricing in aggressive future growth that is not yet visible in current profitability. Without evidence of rapidly accelerating earnings, the risk of multiple compression is elevated.
Price action is currently constructive: the stock is trading well above its 200-day moving average and has risen 7.4% over the last month. The RSI at 61.79 indicates positive momentum without yet being in overbought territory, supporting a near-term bullish technical stance.
Alternative data show a mixed picture: social media presence is large but mostly flat to slightly declining, and job postings have dropped, which could signal either efficiency gains or slower expansion. Web traffic appears modest and does not signal a strong demand surge.
Medicover AB (publ) shows strong positive price momentum and a clear technical uptrend, but this is set against a very rich valuation and only modest earnings. Alternative data are broadly stable rather than strongly expansionary, leaving the overall picture balanced between upside momentum and valuation risk.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started